Decreasing choline signal--a marker of phenylketonuria?
Jazyk angličtina Země Německo Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
9220406
DOI
10.1007/bf01772005
Knihovny.cz E-zdroje
- MeSH
- biologické markery MeSH
- cholin metabolismus MeSH
- dítě MeSH
- dospělí MeSH
- fenylketonurie diagnóza metabolismus MeSH
- kreatin metabolismus MeSH
- kyselina asparagová analogy a deriváty metabolismus MeSH
- lidé MeSH
- magnetická rezonanční spektroskopie metody MeSH
- mladiství MeSH
- protony MeSH
- studie případů a kontrol MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- biologické markery MeSH
- cholin MeSH
- kreatin MeSH
- kyselina asparagová MeSH
- N-acetylaspartate MeSH Prohlížeč
- protony MeSH
We found a statistically significant increase in the N-acetylaspartate/choline-containing compounds (NAA/Cho) ratio in a group of 69 phenylketonuria (PKU) patients with a rise in echo time (TE) compared with a group of 35 age-matched controls. The absolute concentration of creatine did not differ significantly between patients and controls, but a significant difference was found for choline-containing compounds (1.33 mM in patients vs. 1.53 mM in controls, p < 0.0209). The change in NAA/Cho (for TE = 270 ms: 2.52 in patients vs. 1.96 in controls, p270 < 0.0001) can be explained by a significant difference in T2 values of choline compounds between patients and controls. This result shows that the difference in the ratios of signal intensities often used for the description of different pathologies can be explained not only by changes in the absolute metabolite concentration but also by changes in the mobility reflected by relaxation times.
Zobrazit více v PubMed
Pediatr Res. 1995 Feb;37(2):244-9 PubMed
Magn Reson Med. 1994 Jan;31(1):53-7 PubMed
Neuropediatrics. 1995 Aug;26(4):199-202 PubMed
Pediatr Radiol. 1992;22(3):223-4 PubMed
Eur J Pediatr. 1993 Oct;152(10):822-7 PubMed
Neuropediatrics. 1992 Oct;23(5):263-7 PubMed
J Inherit Metab Dis. 1989;12(4):451-7 PubMed
JAMA. 1995 Sep 20;274(11):902-7 PubMed
Magn Reson Med. 1989 Jul;11(1):47-63 PubMed
Life Sci. 1996;58(22):1929-35 PubMed
Rofo. 1995 Sep;163(3):238-44 PubMed
J Comput Assist Tomogr. 1990 May-Jun;14(3):458-60 PubMed
NMR Biomed. 1993 Jan-Feb;6(1):89-94 PubMed
Lancet. 1994 Jul 9;344(8915):87-90 PubMed
Neuropediatrics. 1993 Dec;24(6):302-6 PubMed
Brain. 1993 Aug;116 ( Pt 4):811-21 PubMed
Lancet. 1991 May 18;337(8751):1224 PubMed
Radiology. 1990 Nov;177(2):437-40 PubMed
Magn Reson Med. 1991 Jun;19(2):439-45 PubMed
Brain Dev. 1993 Sep-Oct;15(5):367-71 PubMed
J Pediatr. 1995 Oct;127(4):511-7 PubMed
Eur J Pediatr. 1993 Dec;152(12):1012-20 PubMed
Neuropediatrics. 1993 Apr;24(2):111-2 PubMed
AJNR Am J Neuroradiol. 1991 May-Jun;12(3):403-6 PubMed
J Inherit Metab Dis. 1993;16(6):1047-8 PubMed
Eur J Pediatr. 1991 Jan;150(3):185-9 PubMed
NMR Biomed. 1991 Apr;4(2):90-8 PubMed
